ISRA VISION Neutral

Size: px
Start display at page:

Download "ISRA VISION Neutral"

Transcription

1 Update Note Closing price as of 1/8/17: September 217 Company / Sector Fair Value Recommendation ISRA VISION 128. Neutral Technology: Machine Vision ( 128.) (unchanged) Solid Q3 leaves company on track Share price performance /15 3/16 9/16 3/17 Volume Close Investment case The swing in Q3 earnings was a bit less pronounced than we had forecasted but figures nonetheless were sound, particularly free cash generation. The only fly in the ointment was a marginal y-o-y decline in order backlog which mgmt explained with the expansion of the productive capacity. We therefore adjust our model only marginally and our fair value remains at EUR128. This is still below the current share price but as news flow on acquisitions should support the share price our rating remains Neutral. Share data Reuters ISRG.DE Bloomberg ISR.GY No. of shares (m) 4.38 Daily turnover (3m) 7,31 Free float 7% Market cap. (m) EV (m) Valuation 217e 218e EV/Sales EV/ EBITDA EV/EBIT PER Div. yield.3%.3% RoCE 11.7% 12.9% RoE 1.6% 1.9% Q3 RESULTS ROUGHLY IN LINE Q3 sales (EUR34.4m/+11%) were slightly higher than expected (e: EUR34m), which compensated for slightly higher operating costs so that EBITDA (EUR1m) came in bang in line. Mainly due to higher depreciation net earnings remained slightly below our forecast. Order backlog was lower than anticipated (EUR83m /-2% vs. e: EUR91m). STRONG FREE CASH GENERATION 9M OCF also came in solid (EUR23.3m/ +1%) of which EUR13.8m/+12% remained as free cash. MGMT REITERATES FY16/17 TARGETS Mgmt reiterated its FY16/17 targets of sales growth of approx. 1% and at least stable margins. In addition, mgmt stated that the decrease in order backlog is a result of the expansion of the productive capacity and that order intake is currently high. No acquisition project has yet been finalized but mgmt is still working on this side. OUR FAIR VALUE REMAINS EUR128 We stick to our top line forecast but slightly lower our bottom line expectation, mainly as a result of the higher depreciation. As this has no impact on our DCF model our fair value remains at EUR128. For additional disclosures please refer to the appendix Analyst Forecasts 22e Dr. Anne Gronski Sales Tel.: EBITDA anne.gronski@matelan.de EBIT Adj. EPS Adrian Hopkinson CFA Dividend Tel.: Oper. CF adrian.hopkinson@matelan.de Free CF

2 Q3 16/17 review and changes in our FY16/17 forecast Q3 16/17 Q3 15/16 9M 16/17 9M 15/16 FY 216/17e m estimated reported reported % reported reported % new old % Net sales % % % Capitalized items % Total Output % % % Gross profit % % % Gross margin 61.3% 61.% 61.2% 61.3% 61.3% 61.1% 61.1% EBITDA % % % EBITDA margin 27.2% 27.1% 26.6% 27.9% 27.4% 26.7% 26.8% EBIT % % % EBIT margin 19.1% 18.% 18.% 18.% 18.1% 17.2% 18.% EBT % % % EBT margin 18.8% 17.8% 17.5% 17.7% 17.6% 17.% 17.8% Net income % % % Net margin 13.6% 12.4% 12.3% 12.2% 12.4% 11.8% 12.4% EPS % % % Order backlog % Source: ISRA Vision, Matelan Research Segment reporting EURm Q3 16/17 Q3 15/16 % Sales Industrial Automation % Surface Vision % Total % EBIT Industrial Automation % EBIT-Margin 2.4% 21.2% Surface Vision % EBIT-Margin 19.2% 19.% Total % Key cash flow figures M 15/16 9M 16/17 Cash earnings Change of NWC Capex Free cash flow (r.s.) M as %age of FY 9M as % of FY 216/17e 215/16 214/ / /13 211/12 Net sales 65% 65% 68% 68% 63% 69% EBIT 66% 65% 64% 67% 69% 69% EBT 66% 64% 65% 67% 68% 68% EPS 65% 65% 65% 68% 65% 65% Source: ISRA Vision, Matelan Research - 2 -

3 Sales and EBIT margin Adj. EPS and DPS % 2.% 15.% 1.% 5.%.% % 18% 16% 14% 12% 1% 8% 6% 4% 2% % Industrial Autom. EBIT margin (r.s.) Surface Inspection Adj. EPS EPS growth (r.s.) DPS Cash Flow RoCE % 12.% 9.% % % % Cash Earnings Capex Change in NWC Free Cash Flow (r.s.) Intangibles NWC PPE RoCE (r.s.) Balance Sheet Shareholder structure Assets Liabilities Intangibles Tangibles Working Cap. Other Assets Cash Equity Pensions Financial debt Working Cap. Other Liab. 4.2% 3.2% 3.1% 3.3% 4.7% 25.4% 5.% 4.9% 1.1% Ersü FMR Vision GbR CI Global Univers. Inv. Argos DWS Panamerica Other - 3 -

4 P & L EURm Sales Growth 9.5% 14.8% 11.% 8.% 8.% Material costs Gross profit Gross margin 67.1% 67.4% 66.8% 67.1% 67.2% Other operating costs EBITDA Margin 28.9% 29.2% 29.2% 3.2% 3.7% Depreciation EBIT Margin 2.1% 19.9% 18.8% 19.8% 2.3% Financial result EBT Taxes Net profit Minorities Net profit a.m Growth 14.% 18.5% 4.9% 14.1% 1.7% No of shares EPS Adj. EPS Growth 14.2% 18.3% 4.9% 14.1% 1.7% Dividend Balance Sheet EURm Intangible assets Tangible assets Participations Other non-current assets Non-current assets Inventories Receivables Cash Other current assets Current Assets Total assets Equity Minorities Total equity LT financial liabilities..... Pension provisions Other LT liabilities Non-current liabilities ST financial liabilities Payables Other ST liabilities Current liabilities Total liabilities Cash Flow EURm EBIT Depreciation Other non-cash items Cash taxes Cash earnings Change in NWC CF from operations Capex Other investm./divestm CF from investing CF from fin. and other Change in cash Segments EURm Industrial Automation Growth 6.2% 17.1% 14.1% 11.% 8.% Surface Inspection Growth 1.6% 14.1% 1.% 7.% 8.% Sales Growth 9.5% 14.8% 11.% 8.% 8.% Industrial Automation Margin 2.1% 2.% 16.4% 19.4% 19.5% Surface Inspection Margin 2.1% 19.8% 19.6% 2.% 2.6% EBIT Margin 2.1% 19.9% 18.8% 19.8% 2.3% Valuation multiples Share price x No of shares Market Capitalisation Net financial debt Pension provision Minorities Participations Enterprise Value Sales Adj. EBITDA Adj. EBIT Adj. Net profit a.m EV / Sales EV / EBITDA EV / EBIT PE Source: MATELAN Research, margins are calculated as percentage of sales Key operational indicators Equity ratio 55.8% 59.8% 6.7% 62.1% 63.4% Gearing Asset turnover NWC / sales 94.2% 85.3% 78.7% 78.6% 78.4% Payable days outstanding Receivable days outstandi Fix operating assets NWC Capital employed RoE 1.3% 11.% 1.6% 1.9% 1.9% RoA 8.8% 9.7% 9.4% 9.9% 1.1% RoCE 1.% 11.2% 11.7% 12.9% 13.7% Gross margin 67.1% 67.4% 66.8% 67.1% 67.2% EBITDA margin 28.9% 29.2% 29.2% 3.2% 3.7% EBIT margin 2.1% 19.9% 18.8% 19.8% 2.3% Net profit margin 13.2% 13.6% 12.9% 13.6% 14.% - 4 -

5 ADDITIONAL DISCLOSURES This report has been prepared by MATELAN Research GmbH, Koblenzer Str. 79, Bonn. All rights are reserved. Copyrights and database rights protection exists in this publication. It may not be reproduced or redistributed without prior express permission of Matelan. (1) Analyst certification The analysts responsible for the content of this research report hereby certify that (1) all views expressed in this report accurately reflect their views about any and all of the subject securities or issuers and (2) no part of their compensation was, is or will be directly or indirectly related to the specific recommendation(s) or view(s) of this report. Matelan may have sent extracts of this research report to the subject company for the purpose of verifying factual accuracy. The information provided by the latter was taken into consideration in the report. However, this entailed no change of the assessment. (2) Disclosures about potential conflicts of interest MATELAN Research GmbH has/will receive(d) compensation for research and advisory services provided in the current calendar year from the following companies: ISRA Vision AG. (3) Rating definitions Security firms use a variety of rating terms and systems. Investors should carefully read the definitions of the rating system used in each research report. In addition, since the research report contains more complete information concerning analyst s views, investors should carefully read the entire research report and not infer its contents from the ratings alone. In any case, ratings (or research) should not be used or relied upon as investment advice. An investor s decision to buy or sell a stock should depend on individual circumstances (such as the investor s existing holdings) and other considerations. MATELAN Research GmbH uses an absolute rating system, which varies considerably from relative rating systems (such as Overweight, Equal Weight or Underweight ). Stock ratings are defined as follows: Strong Buy: In the next 6 to 12 months, we expect a potential absolute change in value of over 2% with high forecast certainty. Buy: In the next 6 to 12 months, we expect a potential absolute change in value of more than 1%. Neutral: In the next 6 to 12 months, we expect a potential absolute change in value of over % up to a maximum of 1%. Reduce: In the next 6 to 12 months, we expect a potential absolute negative change in value of up to -1%. Sell: In the next 6 to 12 months, we expect a potential absolute negative change in value of over -1 % with high forecast certainty. The change in stock price results from the difference between the current share price and the analyst s performance expectations, which are generally based on a fair value calculation performed on the basis of a discounted cash flow model and a key comparison analysis but can also consider other effects such as market sentiment. (4) Rating distribution Stock ratings within the coverage universe of MATELAN Research GmbH as of the publication date of this report are distributed as follows: Strong Buy: 15.4% Buy: 53.8% Neutral: 3.8% Reduce:.% Sell:.% (5) Additional information for clients in Germany and other countries This research report has been produced in Germany. It was approved and distributed by MATELAN Research GmbH, which is authorized by the Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin). Laws and regulations in other countries may also restrict the distribution of this report. Persons in possession of this document should inform themselves about possible legal restrictions and observe them accordingly. In particular, this document may not be distributed in the United States, Canada, Australia or Japan or to any U.S. person

6 (6) Recommendation history Stock ratings for the companies covered in this report have developed as follows: ISRA Date Rating 1/9/16 Neutral 7/8/15 Buy 2/3/15 Neutral 16/8/13 Buy 27/5/13 Neutral 18/3/8 Buy 29/8/7 Neutral 24/7/7 Str. Buy 14/5/7 Neutral 2/5/7 Buy DISCLAIMER This research publication has been prepared by MATELAN analysts based on publicly available data that is believed to be accurate and complete. While reasonable care has been taken to ensure that the information contained herein is not untrue or misleading at the time of publication, MATELAN provides no representation or warranty in relation to its accuracy, completeness or reliability. Possible errors or incompleteness of the information do not constitute grounds for liability, either with regard to indirect or to direct or consequential damages. In particular, MATELAN is not liable for the statements, plans or other details contained in the information concerning the examined companies, strategies, economic situations, market and competitive situations, regulatory environment, etc. Neither MATELAN nor its employees are liable for the accuracy and completeness of the statements, estimates and conclusions derived from the information contained in this report. To the extent this research report is being transmitted in connection with an existing contractual relationship, e.g. financial advisory or similar services, the liability of MATELAN shall be restricted to gross negligence and wilful misconduct. In any case, the liability of MATELAN is limited to typical, foreseeable damages and liability for any indirect damages is excluded. This report does not constitute an offer to sell, or a solicitation of an offer to purchase, any security. MATELAN may perform services to other companies mentioned in this report. Directors or employees of MATELAN may serve on the board of directors of companies mentioned in this report. Any opinions contained herein are subject to change without notice. The analysis contained herein is based on numerous assumptions. Different assumptions could result in materially different results. MATELAN does not accept any liability for any loss or damage out of the use of all or any part of this report. Additional information will be made available upon request. Past performance is not necessarily indicative of future results. Investors should make their own investment decisions without relying on this publication. Only investors with sufficient knowledge and experience in financial matters to evaluate the merits and risks should consider an investment in any issuers or market discussed herein and other persons should not take any action on the basis of this publication. Any investments referred to herein may involve significant risk, are not necessarily available in all jurisdictions, may be illiquid and not be suitable for all investors. The price of securities may decrease or increase and as a result investors may lose the amount originally invested. Changes in exchange rates may also cause the value of investments to decrease or increase. Any documents or information we provide is solely for informational purposes and directed only to persons we reasonably believe to be investment professionals. All such communications and any activity to which they relate are available only to such investment professionals; any activity arising from such communications will only be carried out with investment professionals. Persons who do not have professional experience in matters relating to investments shout not rely upon such communications. CONTACT DATA For further information please contact: Matelan Research GmbH Koblenzer Straße Bonn Head Analyst: Dr. Anne Gronski Tel: anne.gronski@matelan.de - 6 -

Advanced Vision Techn Buy

Advanced Vision Techn Buy 16/9/13 16/11/13 16/1/14 16/3/14 16/5/14 16/7/14 16/9/14 16/11/14 16/1/15 16/3/15 16/5/15 16/7/15 MATELAN Research Update Note Closing price as of 13/8/15: 9.16 14 August 215 Company / Sector Fair Value

More information

BDI BioEnergy Internat Buy

BDI BioEnergy Internat Buy 13/08/12 13/10/12 13/12/12 13/02/13 13/04/13 13/06/13 13/08/13 13/10/13 13/12/13 13/02/14 13/04/14 13/06/14 13/08/14 MATELAN Research Update Note Price as of 13/08/14: 10.29 14 August 2014 Company / Sector

More information

MATELAN Research. InVision 49.0 Buy. Excellent margin trend in Prelims. Update Note. 24 February Company / Sector Fair Value Recommendation

MATELAN Research. InVision 49.0 Buy. Excellent margin trend in Prelims. Update Note. 24 February Company / Sector Fair Value Recommendation Update Note Price as of 21/02/13: 4 24 February 2014 Company / Sector Fair Value Recommendation InVision 49.0 Buy Technology: Cloud Computing ( 34) (Buy) Excellent margin trend in Prelims Share price performance

More information

Solid preliminary FY 2014 results released. Net asset value increased by 3.5% in H 2014 with difficult trading environment

Solid preliminary FY 2014 results released. Net asset value increased by 3.5% in H 2014 with difficult trading environment A cc or # $T ypcap$ 1628 1 0 4 2 Equity flash Trading Update Financial Services Scherzer & Co. AG BUY (BUY) Target 1.80 EUR (1.80 EUR) Price (last closing price) : 1.56 EUR Upside : 15% Est.. change 2015e

More information

Electronics Line 3000 Ltd.

Electronics Line 3000 Ltd. June 18, 2013 Information Analysis Analysts Dr. Roger Becker, CEFA David Szabadvari +49 69 71 91 838-46, -48 roger.becker@bankm.de, david.szabadvari@bankm.de Evaluation result Fair value BUY 0.88 (previous

More information

BUY (previous: BUY) (previous: 77.50)

BUY (previous: BUY) (previous: 77.50) November 10, 2017 Information Analysis Analyst: Daniel Grossjohann +49 69 71 91 838-42 Daniel.grossjohann@bankm.de Evaluation result Fair value BUY 75.65 (previous: BUY) (previous: 77.50) Find BankM Research

More information

PA Power Automation AG

PA Power Automation AG February 08, 2017 Information Analysis Analysts: Daniel Großjohann, Dr. Roger Becker, CEFA +49 69 71 91 838-42, -46 daniel.grossjohann@bankm.de, roger.becker@bankm.de Evaluation result Fair value HOLD

More information

Evaluation result Fair value DPS. adj. net. adj. EPS ( )

Evaluation result Fair value DPS. adj. net. adj. EPS ( ) May 27, 2010 Information analysis Evaluation result Fair value Analyst BUY 1.73 Dr. Roger Becker, CEFA, Biologist +49 69 71 91 838-46 roger.becker@bankm.de (previously BUY) (previously 1.73) Acquisition

More information

GOING EAST & ONE YEAR AFTER

GOING EAST & ONE YEAR AFTER Givaudan Chemicals Neutral Fair Value CHF1050.00 2007-11-22 Price CHF1044.00 (Closing price as of 2007-11-21) Applied disclosures can be found in the appendix Price and rel. Performance GOING EAST & ONE

More information

Very solid Q3; excellent story, but priced in; TP upped to 60.00; downgrade to neutral. Q3 2016: Very solid quarter, better than expected

Very solid Q3; excellent story, but priced in; TP upped to 60.00; downgrade to neutral. Q3 2016: Very solid quarter, better than expected B a sl er A G # $T ypcap$ 1576 14 1 1 x 6495 2 Page 1/6 First Take Reco. lowered Neutral vs Buy Electronics Germany Neutral Target price : 60.00 EUR vs 52.00 EUR Price (11/01/2016) : 58.04 EUR Upside :

More information

SFC Energy AG STRONG GROWTH AND PROFITABILITY AHEAD. FIRST BERLIN Equity Research. Preliminary PRICE TARGET S F

SFC Energy AG STRONG GROWTH AND PROFITABILITY AHEAD. FIRST BERLIN Equity Research. Preliminary PRICE TARGET S F FIRST BERLIN Equity Research SFC Energy AG RATING Germany / Energy Preliminary Primary exchange: Frankfurt PRICE TARGET 8.70 Bloomberg: F3C GR 2017 figures Return Potential 13.3% ISIN: DE0007568578 Risk

More information

HAEMATO AG SOLID UPTICK IN H2 SALES AND EBIT MARGIN. FIRST BERLIN Equity Research PRICE TARGET H A

HAEMATO AG SOLID UPTICK IN H2 SALES AND EBIT MARGIN. FIRST BERLIN Equity Research PRICE TARGET H A FIRST BERLIN Equity Research HAEMATO AG RATING Germany / Pharma 2017 Frankfurt PRICE TARGET 7.40 Bloomberg: HAE GR Prelims Return Potential 25.4% ISIN: DE0006190705 Risk Rating High SOLID UPTICK IN H2

More information

HOLD 51,85. (previous: Hold) (previous: 51,65)

HOLD 51,85. (previous: Hold) (previous: 51,65) August 12, 2015 Information Analysis Analyst Daniel Großjohann +49 69 71 91 838-42 daniel.grossjohann@bankm.de Evaluation result Fair value HOLD 51,85 (previous: Hold) (previous: 51,65) BankM Research

More information

13 May 2016 PNE WIND AG. FIRST BERLIN Equity Research

13 May 2016 PNE WIND AG. FIRST BERLIN Equity Research FIRST BERLIN Equity Research PNE WIND AG RATING Germany / Cleantech Primary exchange: Frankfurt Q1/16 figures PRICE TARGET 3.30 Bloomberg: PNE3 GR Return Potential 50.1% ISIN: DE000A0JBPG2 Risk Rating

More information

TEMPORARILY NO VALUATION. (previous: not rated)

TEMPORARILY NO VALUATION. (previous: not rated) 23. Dezember 2013 Information analysis Analysts Dr. Roger Becker, CEFA David Szabadvari +49 69 71 91 838-46, -48 roger.becker@bankm.de, david.szabadvari@bankm.de Valuation Result TEMPORARILY NO VALUATION

More information

Borussia Dortmund GmbH & Co. KGaA

Borussia Dortmund GmbH & Co. KGaA A cc or # 6 $T ypcap$ 1628 1 0 4 2 Page 1/7 Equity flash Trading Update Entertainment BUY (BUY) Target EUR 5.00 (EUR 5.00) Price (last closing price) : EUR 3.91 Upside : 28% Est. change 2015e 2016e EPS

More information

PA Power Automation AG

PA Power Automation AG September 29, 2017 Information Analysis Analysts: Daniel Großjohann, Dr. Roger Becker, CEFA +49 69 71 91 838-42, -46 daniel.grossjohann@bankm.de, roger.becker@bankm.de Evaluation result NOT RATED - Fair

More information

18 October 2016 aventron AG. FIRST BERLIN Equity Research

18 October 2016 aventron AG. FIRST BERLIN Equity Research FIRST BERLIN Equity Research aventron AG RATING Switzerland / Renewable Energy Berner Börse H1 figures PRICE TARGET CHF13.00 Bloomberg: AVEN SW Return Potential 47.7% ISIN: CH0023777235 Risk Rating medium

More information

17 May 2016 ISARIA Wohnbau AG. FIRST BERLIN Equity Research

17 May 2016 ISARIA Wohnbau AG. FIRST BERLIN Equity Research FIRST BERLIN Equity Research ISARIA Wohnbau AG RATING Germany / Real estate Frankfurt Q1/16 Results PRICE TARGET 5.70 Bloomberg: IWB GR Return Potential 71.8% ISIN: DE000A1E8H38 Risk Rating High SLOW Q1

More information

1 November 2017 M1 Kliniken AG. FIRST BERLIN Equity Research. Update following

1 November 2017 M1 Kliniken AG. FIRST BERLIN Equity Research. Update following FIRST BERLIN Equity Research M1 Kliniken AG RATING Germany / Healthcare Facilities & Services Update following Frankfurt PRICE TARGET 16.50 Bloomberg: M12 GR capital increase Return Potential 44.7% ISIN:

More information

Buy. Straumann Price CHF (Closing price as of ) Applied disclosures can be found in the appendix

Buy. Straumann Price CHF (Closing price as of ) Applied disclosures can be found in the appendix Straumann Buy Health Care Fair Value CHF360.00 2008-02-08 Price CHF291.00 (Closing price as of 2008-02-07) Applied disclosures can be found in the appendix PRICE AND REL. PERFORMANCE FEEDBACK FROM CONF

More information

Intershop Communications AG

Intershop Communications AG FIRST BERLIN Equity Research Intershop Communications AG RATING GERMANY / Technology Primary Exchange: Frankfurt Q2 figures PRICE TARGET 1.44 Bloomberg: ISH2 GR Return Potential -15.2% ISIN: DE000A0EPUH1

More information

NOT RATED. (previously Buy) (previously 1.73) adj. net (mln ) DPS ( ) adj. EPS ( )

NOT RATED. (previously Buy) (previously 1.73) adj. net (mln ) DPS ( ) adj. EPS ( ) 7 September 2010 Information analysis Analyst Dr. Roger Becker, CEFA, Biologist +49 69 71 91 838-46 roger.becker@bankm.de Evaluation result NOT RATED Fair value (previously Buy) (previously 1.73) Sales

More information

27 March 2019 SFC Energy AG. FIRST BERLIN Equity Research. Final SUSTAINABLE MACRO TRENDS SUPPORT FUEL CELL BUSINESS

27 March 2019 SFC Energy AG. FIRST BERLIN Equity Research. Final SUSTAINABLE MACRO TRENDS SUPPORT FUEL CELL BUSINESS FIRST BERLIN Equity Research SFC Energy AG RATING Germany / Energy Final Primary exchange: Frankfurt PRICE TARGET 11.20 Bloomberg: F3C GR 2018 figures Return Potential 13.1% ISIN: DE0007568578 Risk Rating

More information

Evaluation result Fair value BUY (prev.: BUY) (prev.: 21.52)

Evaluation result Fair value BUY (prev.: BUY) (prev.: 21.52) September 05, 2013 Information Analysis Evaluation result Fair value Analysts Dr. Roger Becker, CEFA David Szabadvari +49 69 71 91 838-46, -48 roger.becker@bankm.de, david.szabadvari@bankm.de Solid Growth,

More information

SABIC Overall strong performance

SABIC Overall strong performance SABIC AB: Saudi Arabia US$80.80bn 22.6% US$124.7mn Market cap Free float Avg. daily volume RSI10 Vol th Target price 126.0 24.75% over current Consensus price 125.6 24.4% over current Current price 101.0

More information

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance RAMCO S HOLD Target Price: Rs 503 Deleveraging story playing out Ramco Cements total debt reduced by a massive Rs 5 bn to Rs 22 bn in FY16. The company generated total EBITDA of Rs 11.5 bn in FY16 and

More information

HOLD (previous: BUY) (previous: 68.00)

HOLD (previous: BUY) (previous: 68.00) February 23, 2017 Information Analysis Analyst Daniel Großjohann +49 69 71 91 838-42 daniel.grossjohann@bankm.de Evaluation Result Fair Value HOLD 69.00 (previous: BUY) (previous: 68.00) BankM Research

More information

Results Review. 3QFY13: Downsizing its workforce. Technology Bloomberg Ticker: UNI MK Bursa Code: November 2013

Results Review. 3QFY13: Downsizing its workforce. Technology Bloomberg Ticker: UNI MK Bursa Code: November 2013 Results Review (Member of Alliance Bank group) PP7766/03/2013 (032116) 8 November 2013 Analyst Toh Woo Kim wookim@alliancefg.com +603 2604 3917 12-month upside potential Previous target price 0.89 Revised

More information

7C Solarparken GUIDANCE FOR 2016 INCREASED. FIRST BERLIN Equity Research. Preliminary 2014 PRICE TARGET 2.10

7C Solarparken GUIDANCE FOR 2016 INCREASED. FIRST BERLIN Equity Research. Preliminary 2014 PRICE TARGET 2.10 FIRST BERLIN Equity Research 12 7C Solarparken AG 7 RATING Germany / Cleantech Preliminary 2014 Primary Exchange: Frankfurt PRICE TARGET 2.10 Bloomberg: HRPK GF figures Return Potential 13.9% ISIN: DE000A11QW68

More information

18 November 2016 Energiekontor AG. FIRST BERLIN Equity Research

18 November 2016 Energiekontor AG. FIRST BERLIN Equity Research FIRST BERLIN Equity Research Energiekontor AG RATING Germany / Cleantech Frankfurt Stock Exchange 9M report PRICE TARGET 19.70 Bloomberg: EKT GR Return Potential 31.3% ISIN: DE0005313506 Risk Rating High

More information

Leifheit AG. Management Meeting confirms our positive view. Buy (Buy) EUR (60.00 EUR ) BANKHAUS LAMPE // 1 16/02/2016

Leifheit AG. Management Meeting confirms our positive view. Buy (Buy) EUR (60.00 EUR ) BANKHAUS LAMPE // 1 16/02/2016 BANKHAUS LAMPE // 1 Leifheit AG Management Meeting confirms our positive view 16/02/2016 Buy (Buy) 60.00 EUR (60.00 EUR ) Close 12/02/2016 45.00 EUR Bloomberg: LEI GY WKN: 646450 Sector Consumer Share

More information

Yansab Better than expected results

Yansab Better than expected results YANSAB AB: Saudi Arabia US$6.91bn 39.8% US$23.37mn Market cap Free float Avg. daily volume RSI10 Vol th Target price n/a n/a Consensus price 56.00 21.5% over current Current price 46.10 as at 9/2/2011

More information

ContextVision. Expecting solid results and awaiting progress update on research program

ContextVision. Expecting solid results and awaiting progress update on research program 1Q17 Preview (report due April 27 th ) April 24 th 2017 Share price: NOK 61.75 Target: NOK 100.00 (unchanged) Risk: Medium ContextVision Key share data Sector Reuters Bloomberg Health Care COVI.OL COV

More information

Zain KSA restructuring ensures fresh start

Zain KSA restructuring ensures fresh start Vol mn RSI10 Zain KSA ZAINKSA AB: Saudi Arabia US$5.41bn 48.3% US$142.1mn Market cap Free float Avg. daily volume Target price 15.90 9.68% over current Consensus price 16.10 11.0% over current Current

More information

Key estimate revision. Financial summary. Year FY14 391,088 45,198 34, FY15E 354,262 35,426 23,

Key estimate revision. Financial summary. Year FY14 391,088 45,198 34, FY15E 354,262 35,426 23, : price: EPS: How does our one year outlook change? We retain our negative stance on the stock. We expect s revenue to de-grow by 9% y-o-y on the back of muted execution (client side and clearance delays)

More information

CLERE AG DELISTING & TAKEOVER BID BY MAIN SHAREHOLDER. FIRST BERLIN Equity Research. Delisting & PRICE TARGET C L

CLERE AG DELISTING & TAKEOVER BID BY MAIN SHAREHOLDER. FIRST BERLIN Equity Research. Delisting & PRICE TARGET C L CLERE AG RATING Germany / Cleantech Delisting & Primary exchange: XETRA PRICE TARGET 16.33 Bloomberg: CAG GR takeover bid Return Potential 1.8% ISIN: DE0005215107 Risk Rating Medium DELISTING & TAKEOVER

More information

Advanced Vision Technology

Advanced Vision Technology FIRST BERLIN Equity Research Advanced Vision Technology Ltd RATING Israel / Machine Vision Technology Q3/16 Primary exchange: Frankfurt PRICE TARGET 11.70 / $12.70 Bloomberg: VSJ GR Results Return Potential

More information

PNE WIND AG OFFSHORE PROJECT ATLANTIS I SOLD. FIRST BERLIN Equity Research. Good start to PRICE TARGET P N

PNE WIND AG OFFSHORE PROJECT ATLANTIS I SOLD. FIRST BERLIN Equity Research. Good start to PRICE TARGET P N FIRST BERLIN Equity Research PNE WIND AG RATING Germany / Cleantech Good start to Primary exchange: Frankfurt PRICE TARGET 3.00 Bloomberg: PNE3 GR the new year Return Potential 43.8% ISIN: DE000A0JBPG2

More information

14 August 2017 PNE WIND AG. FIRST BERLIN Equity Research

14 August 2017 PNE WIND AG. FIRST BERLIN Equity Research FIRST BERLIN Equity Research PNE WIND AG RATING Germany / Cleantech Primary exchange: Frankfurt Q2 figures PRICE TARGET 3.50 Bloomberg: PNE3 GR Return Potential 33.5% ISIN: DE000A0JBPG2 Risk Rating High

More information

Research Note. Fair Value REIT-AG

Research Note. Fair Value REIT-AG Independent Research Unabhängige Finanzmarktanalyse GmbH Research Note Fair Value REIT-AG Preliminary results 2011 Please take note of the information concerning the preparation of this document, the informa-tion

More information

ContextVision. Neutral stance maintained after 3Q. 3Q14 Results analysis November 5 th 2014 Share price: NOK Target: NOK 24.

ContextVision. Neutral stance maintained after 3Q. 3Q14 Results analysis November 5 th 2014 Share price: NOK Target: NOK 24. 3Q14 Results analysis November 5 th 2014 Share price: NOK 22.00 Target: NOK 24.00 Risk: Medium ContextVision Key share data Sector Reuters Bloomberg ContextVision is a market making client of Norne Securities

More information

Daewoo E&C ( KS) WHAT S THE STORY?

Daewoo E&C ( KS) WHAT S THE STORY? Company Update (047040 KS) All-round margin improvements WHAT S THE STORY? Event: yesterday after market close reported that its parentbased operating profit hit KRW107.6b in 3Q, vs the consolidated consensus

More information

ContextVision. Solid 2Q and more details on the contract awaited. August 18 th 2014 Share price: NOK Target: NOK Risk: Medium.

ContextVision. Solid 2Q and more details on the contract awaited. August 18 th 2014 Share price: NOK Target: NOK Risk: Medium. August 18 th 2014 Share price: NOK 21.70 Target: NOK 24.00 Risk: Medium ContextVision Key share data Sector Reuters Bloomberg Health Care COVI.OL COV:NO Market Cap (NOKm) 167.9 Net debt (NOKm) -28.6 EV

More information

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E RAMCO S BUY Target Price: Rs 435 Efforts on cost cutting paying off Q2 EBITDA at Rs 2.8 bn (up 30% YoY) was ahead of our estimates due to lower-than-expected costs. Average costs (excluding freight) declined

More information

Petro Rabigh Shutdown marred Q2 results

Petro Rabigh Shutdown marred Q2 results PETROR AB: Saudi Arabia US$5.07bn 17.4% US$11.19mn Market cap Free float Avg. daily volume RSI10 Vol th Target price n/a n/a Consensus price 32.18 48.3% over current Current price 21.70 as at 17/8/2011

More information

- 2/7 - Segment Discussion August 05, Segment Discussion. Stock and Valuation

- 2/7 - Segment Discussion August 05, Segment Discussion. Stock and Valuation August 05, 2011 Information Analysis Analyst Dr. Roger Becker, CEFA, Biologist +49 69 71 91 838-46 roger.becker@bankm.de Evaluation result Fair value BUY 38.30 (previously BUY) (previously 40.50) H1/2011:

More information

20 April 2018 Energiekontor AG. FIRST BERLIN Equity Research

20 April 2018 Energiekontor AG. FIRST BERLIN Equity Research FIRST BERLIN Equity Research Energiekontor AG RATING Germany / Cleantech Frankfurt Stock Exchange 2017 final figures PRICE TARGET 23.50 Bloomberg: EKT GR Return Potential 72.2% ISIN: DE0005313506 Risk

More information

5 November C Solarparken AG. FIRST BERLIN Equity Research

5 November C Solarparken AG. FIRST BERLIN Equity Research FIRST BERLIN Equity Research 5 7C Solarparken AG 7 RATING Germany / Cleantech Primary Exchange: Frankfurt Next growth phase PRICE TARGET 3.00 Bloomberg: HRPK GF Return Potential 30.4% ISIN: DE000A11QW68

More information

EQUINET INVESTIGATOR

EQUINET INVESTIGATOR Hypoport 2 January 211 Financials Bloomberg: HYQ GR Market Cap: EUR 72m Free Float: 35% Current Share Price: EUR 11.8 Buy / Target EUR 17 Profile Hypoport is an internet-based financial services provider

More information

25 April 2014 OpenLimit Holding AG. FIRST BERLIN Equity Research

25 April 2014 OpenLimit Holding AG. FIRST BERLIN Equity Research FIRST BERLIN Equity Research OpenLimit Holding AG RATING Switzerland / Software Primary exchange: Frankfurt FY 2013 figures PRICE TARGET 1.30 Bloomberg: O5H GR Return Potential 90.1% ISIN: CH0022237009

More information

22 November 2017 Energiekontor AG. FIRST BERLIN Equity Research

22 November 2017 Energiekontor AG. FIRST BERLIN Equity Research FIRST BERLIN Equity Research Energiekontor AG RATING Germany / Cleantech Frankfurt Stock Exchange 9M report PRICE TARGET 24.80 Bloomberg: EKT GR Return Potential 75.1% ISIN: DE0005313506 Risk Rating High

More information

Key estimate revision. Financial summary. Year FY15 121, % 16, % FY16E 137, % 20,

Key estimate revision. Financial summary. Year FY15 121, % 16, % FY16E 137, % 20, : price: EPS: How does our one year outlook change? We maintain rating on Aurobindo post the company s 3QFY16 results. Revenue growth for the quarter was 10% yoy: US sales of $238mn (vs. estimate of $251mn

More information

ad pepper media International N.V.

ad pepper media International N.V. FIRST BERLIN Equity Research ad pepper media International N.V. RATING The Netherlands / Internet Services Frankfurt Final 2017 figures PRICE TARGET 4.80 Bloomberg: APM GR Return Potential 30.4% ISIN:

More information

5 September 2016 OTI Greentech AG. FIRST BERLIN Equity Research

5 September 2016 OTI Greentech AG. FIRST BERLIN Equity Research FIRST BERLIN Equity Research OTI Greentech AG RATING Germany / Cleantech Exchange: Duesseldorf Preliminary H1 figures PRICE TARGET 1.90 Bloomberg: NSA GR Return Potential 280.0% ISIN: DE000A0HNE89 Risk

More information

Neutral (Buy) MLP Price EUR10.30 (Closing price as of ) Applied disclosures can be found in the appendix

Neutral (Buy) MLP Price EUR10.30 (Closing price as of ) Applied disclosures can be found in the appendix MLP Neutral (Buy) Diversified Financials Fair Value EUR9.70 2008-02-13 Price EUR10.30 (Closing price as of 2008-02-11) Applied disclosures can be found in the appendix Price / EUR 28 26 24 22 20 18 16

More information

Reduced EPS but smart acquisition

Reduced EPS but smart acquisition 23 Oktober 2017 MBB SE Rating Buy Share price (EUR) 99.55 Target price (EUR) 130.00 Bloomberg MBB GY Sector - Share data Shares out (m) 6.6 Daily volume shs (m) 1.0 Free float (%) 35.20 Market cap (EUR

More information

6 September 2016 aventron AG. FIRST BERLIN Equity Research

6 September 2016 aventron AG. FIRST BERLIN Equity Research FIRST BERLIN Equity Research aventron AG RATING Switzerland / Renewable Energy Berner Börse Capital increase PRICE TARGET CHF13.00 Bloomberg: AVEN SW Return Potential 52.8% ISIN: CH0023777235 Risk Rating

More information

Adani Ports & SEZ Rating: Target price: EPS:

Adani Ports & SEZ Rating: Target price: EPS: Adani Ports & SEZ : price: EPS: Volume traction continues in a seasonally good quarter; maintain Adani Ports & SEZ reported a good quarter with total operating revenues (standalone) of Rs. 8.02bn and PAT

More information

Indygotech Minerals S.A.

Indygotech Minerals S.A. Indygotech Minerals S.A. Fair Value: n.a. Update Rating: n.a Indygotech Minerals (IDG) share price has recently taken a hit. The reason was a delay of completion of the production facilities for ceramic

More information

J&P Avax. Hefty upside, but no catalysts. Greece, Construction. June 4, 2010

J&P Avax. Hefty upside, but no catalysts. Greece, Construction. June 4, 2010 Greece, Construction J&P Avax Hefty upside, but no catalysts June 4, 2010 Current price 1.45 Target price 5.40 From 6.50 Upside potential 272.4% Remains Outperform Key data Reuters code AVAr.AT Bloomberg

More information

Key ratios Sales adj. net

Key ratios Sales adj. net Date 07/30/2012 Vara Research GmbH Schweizer Straße 13 60594 Frankfurt am Main www.vararesearch.de Buy (formerly: Buy) Design Hotels AG TP: 0.95 (formerly: 0.90) Changes No signs of economic slowdown at

More information

Strong growth ahead QUIRIN PRIVATBANK EQUITY RESEARCH. 18 Mai 2017 EQS Group AG

Strong growth ahead QUIRIN PRIVATBANK EQUITY RESEARCH. 18 Mai 2017 EQS Group AG 18 Mai 2017 EQS Group AG Rating Buy (Buy) Share price (EUR) 52.50 Target price (EUR) 60.00 (50.00) Bloomberg Sector EQS GY Technology Share data Shares out (m) 1.3 Daily volume shs (m) 0.0 Free float (%)

More information

2014 E 2015 E 2016 E 2017 E

2014 E 2015 E 2016 E 2017 E Equity Research 4 December 2014 Interpump Group Hydraulics M&A may power growth Rating BUY Target price EUR13 Interpump is up 25% since the beginning of the year, bolstered by strong interim results and

More information

Kalpataru Power. Rating: Target price: EPS: Rating CMP. Target BUY. Rs Rs.256

Kalpataru Power. Rating: Target price: EPS: Rating CMP. Target BUY. Rs Rs.256 : price: EPS: How does our one year outlook change? We expect KPP s revenue (standalone) to grow by 21% y-o-y in FY17E backed by an order book of Rs. 91bn (1.7x FY17E book-to-bill). Both Transmission line

More information

Dr Reddy s Laboratories

Dr Reddy s Laboratories : price: EPS: How does our one year outlook change? We maintain rating on DRRD post the company s 3QFY16 results Revenue growth for the quarter was muted (3% yoy) due to disappointing performances in Russia

More information

Saudi Ceramic Expansion plan key growth driver

Saudi Ceramic Expansion plan key growth driver RSI10 Construction and Materials Industrial SCERCO AB: Saudi Arabia Rating NEUTRAL Target price SAR116. 0 (4.5% upside) Current SAR111.3 price Key themes & implications Company is one of the leading ceramic

More information

NOW ON APP Research at your finger tips

NOW ON APP Research at your finger tips NOW ON APP Research at your finger tips 15 FEB 2018 Quarterly Update BUY Target Price: Rs 470 ODC project takes breather; to rebound in Q4 Q3 pre-sales declined QoQ to Rs 1 bn (Rs 1.7 bn in Q2) on lower

More information

Air France-KLM. Hold TP 6.50 CP 7.59 (Close 21 October 2013) Q3 due 31 October More restructuring needed. Equity Research Quick Bite Preview

Air France-KLM. Hold TP 6.50 CP 7.59 (Close 21 October 2013) Q3 due 31 October More restructuring needed. Equity Research Quick Bite Preview Equity Research Quick Bite Preview 22 October 2013 Air France-KLM Q3 due 31 October More restructuring needed Supported by lower fuel costs and the ramp up in cost savings, we expect Q3 to deliver a solid

More information

S-Oil (010950) Healthier revenue structure already reflected in valuations

S-Oil (010950) Healthier revenue structure already reflected in valuations S-Oil (010950) Hold (Initiate) Stock price (Sep 15, KRW) 46,000 Market cap (USD mn) 4,989 Shares outstanding (mn) 113 52W High/Low (KRW) 81,200/43,500 6M avg. daily turnover (USD mn) 15.4 Free float (%)

More information

BUY (previous: BUY) (previous: 72.30) DPS ( ) adj. EPS ( )

BUY (previous: BUY) (previous: 72.30) DPS ( ) adj. EPS ( ) January 14, 2019 Information Analysis Analyst: Daniel Grossjohann +49 69 71 91 838-42 Daniel.grossjohann@bankm.de Evaluation result Fair value BUY 70.60 (previous: BUY) (previous: 72.30) Find BankM Research

More information

Evaluation Result Fair Value BUY (previous: BUY) (previous: 65.50)

Evaluation Result Fair Value BUY (previous: BUY) (previous: 65.50) January 23, 2017 Information Analysis Evaluation Result Fair Value Analyst Daniel Großjohann +49 69 71 91 838-42 daniel.grossjohann@bankm.de BUY 68.00 (previous: BUY) (previous: 65.50) BankM Research on

More information

HAEMATO AG MARKET SHARE WIN IN PARALLEL IMPORT BUSINESS. FIRST BERLIN Equity Research H1/18 PRICE TARGET H A

HAEMATO AG MARKET SHARE WIN IN PARALLEL IMPORT BUSINESS. FIRST BERLIN Equity Research H1/18 PRICE TARGET H A FIRST BERLIN Equity Research HAEMATO AG RATING Germany / Pharma H1/18 Frankfurt PRICE TARGET 7.60 Bloomberg: HAE GR results Return Potential 41.8% ISIN: DE0006190705 Risk Rating High MARKET SHARE WIN IN

More information

26 October 2017 Energiekontor AG. FIRST BERLIN Equity Research. Update. Bloomberg: EKT GR Return Potential 67.2% ISIN: DE

26 October 2017 Energiekontor AG. FIRST BERLIN Equity Research. Update. Bloomberg: EKT GR Return Potential 67.2% ISIN: DE FIRST BERLIN Equity Research Energiekontor AG RATING Germany / Cleantech Frankfurt Stock Exchange Update PRICE TARGET 25.00 Bloomberg: EKT GR Return Potential 67.2% ISIN: DE0005313506 Risk Rating High

More information

Zain KSA bogged down by high debt

Zain KSA bogged down by high debt Vol th RSI10 Zain KSA ZAINKSA AB: Saudi Arabia US$2.464bn 48.3% US$16.50mn Market cap Free float Avg. daily volume Target price 7.30 12.31% over current Consensus price 7.62 17.2% over current Current

More information

Adler Real Estate AG. Fewer vacancies, more properties. Buy (Buy) EUR (16.50 EUR ) BANKHAUS LAMPE // 1 28/03/2017

Adler Real Estate AG. Fewer vacancies, more properties. Buy (Buy) EUR (16.50 EUR ) BANKHAUS LAMPE // 1 28/03/2017 BANKHAUS LAMPE // 1 Adler Real Estate AG Fewer vacancies, more properties 28/03/2017 Buy (Buy) 17.00 EUR (16.50 EUR ) Close 24/03/2017 13.92 EUR Bloomberg: ADL GY WKN: 500800 Sector Share price performance

More information

HOLD (previous: Hold) (previous: 51.85)

HOLD (previous: Hold) (previous: 51.85) January 26, 2016 Information Analysis Analyst Daniel Großjohann +49 69 71 91 838-42 daniel.grossjohann@bankm.de Evaluation Result Fair Value HOLD 65.00 (previous: Hold) (previous: 51.85) BankM Research

More information

Klaus Kränzle, Please inform yourself of important disclosures and disclaimers in the appendix

Klaus Kränzle, Please inform yourself of important disclosures and disclaimers in the appendix research Note Consumer & Retail Target price decomposition Consensus SQR (adjust.) 19 October 2012 Neutral, PT EUR25,00, upside 5% published Q3 figures and is optimistic for financial year 2012 - guidance

More information

Buy PT EUR24,00, upside 23%

Buy PT EUR24,00, upside 23% Ludwig Beck AG Consumers & Retail Buy PT EUR24,00, upside 23% Positive start into 2012 Q1 meets our expectations and backs our call Ludwig Beck shares have outperformed the SDAX by 1% y-o-y as the SDAX

More information

Almarai Steady performance

Almarai Steady performance RSI10 ALMARAI AB: Saudi Arabia Rating Target price Current price NEUTRAL SAR55.05 (-4.59% upside) SAR57.66 Key themes & implications Almarai reported a positive top-line in Q1 2016, showing resilience

More information

LUCISANO MEDIA GROUP. New partner for Lucisano. Buy (maintained) Company Update

LUCISANO MEDIA GROUP. New partner for Lucisano. Buy (maintained) Company Update LUCISANO MEDIA GROUP Company Update Buy (maintained) 5:30PM MARKET PRICE: EUR2.82 TARGET PRICE: EUR3.40 (unchanged) Entertainment Data Shares Outstanding (m): 14.88 Market Cap. (EURm): 41.96 Enterprise

More information

24 September 2018 OpenLimit Holding AG. FIRST BERLIN Equity Research

24 September 2018 OpenLimit Holding AG. FIRST BERLIN Equity Research FIRST BERLIN Equity Research OpenLimit Holding AG RATING Switzerland / Software Primary exchange: Frankfurt H1 figures PRICE TARGET 0.50 Bloomberg: O5H GR Return Potential 72.4% ISIN: CH0022237009 Risk

More information

Key estimate revision. Financial summary. Year

Key estimate revision. Financial summary. Year : price: EPS: How does our one year outlook change? We retain our positive outlook on WIL and believe that revival in MHCV industry, increasing content per vehicle and opportunity in exports would drive

More information

National Industrialization Co. Diversified Operations Industrial NIC AB: Saudi Arabia 25 May 2014

National Industrialization Co. Diversified Operations Industrial NIC AB: Saudi Arabia 25 May 2014 RSI10 National Industrialization Co. NIC AB: Saudi Arabia 25 May 2014 Rating Target price Current price OVERWEIGHT SAR37.30 (18.7% upside) SAR31.40 Key themes & implications Sluggish petrochemical prices

More information

Trevi Group Italy Capital goods

Trevi Group Italy Capital goods 30 August 2013 Trevi Group Italy Capital goods Buy (Hold) Target price EUR6.90 Current price EUR6.22 Matteo Bonizzoni, CFA mbonizzoni@keplercheuvreux.com +39 02 80 62 83 43 Sound delivery and business

More information

Itway (ITW.IM) 1H 08/09 results: once again affected by the crisis June 16, 2009

Itway (ITW.IM) 1H 08/09 results: once again affected by the crisis June 16, 2009 Itway (.IM) Sector: IT / Distribution HOLD 1H 08/09 results: once again affected by the crisis June 16, 2009 Investment view Itway is active in the marketing and licensing of technologies for e-business

More information

Ma aden Equity infusion will strengthen balance sheet

Ma aden Equity infusion will strengthen balance sheet RSI10 Ma aden MAADEN AB: Saudi Arabia Rating Target price Current price OVERWEIGHT SAR42.0 (19.4% upside) SAR35.17 Research Department ARC Research Team Tel 966 11 211 9332, gopij@alrajhi-capital.com Key

More information

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights JK 20 NOV 2017 Quarterly Update BUY Target Price: Rs 1,220 White cement steals the show JK Cement s (JKCE) Q2FY18 EBITDA at Rs 2.1 bn (up 30% YoY) was higher than our and consensus estimates, mainly due

More information

26 April 2017 aventron AG. FIRST BERLIN Equity Research

26 April 2017 aventron AG. FIRST BERLIN Equity Research FIRST BERLIN Equity Research aventron AG RATING Switzerland / Renewable Energy Berner Börse 2016 annual figures PRICE TARGET CHF 13.00 Bloomberg: AVEN SW Return Potential 42.9% ISIN: CH0023777235 Risk

More information

Highest single order in paragon s history

Highest single order in paragon s history Paragon AG 1 July 2016 Rating Buy Share price (EUR) 28.52 Target price (EUR) 37.00 Bloomberg Sector Share data PGN GY Technology Shares out (m) 4.1 Daily volume shs (m) 0.2 Free float (%) 48.00 Market

More information

J&P Avax. No catalyst in sight remains cheap. Greece, Construction. April 8, 2010

J&P Avax. No catalyst in sight remains cheap. Greece, Construction. April 8, 2010 Greece, Construction J&P Avax No catalyst in sight remains cheap April 8, 2010 Current price 2.03 Target price 6.50 From 6.40 Upside potential 220.2% Remains Outperform Key data Reuters code AVAr.AT Bloomberg

More information

Simmtech (222800) Focus on 2H earnings WHAT S THE STORY?

Simmtech (222800) Focus on 2H earnings WHAT S THE STORY? Company Update Simmtech (222800) Focus on 2H earnings Simmtech yesterday reported disappointing 4Q results, which compels us to cut our 2018 operating profit forecast by 10% to KRW52.9b and 12-month target

More information

Century Plyboards (India)

Century Plyboards (India) : price: EPS: How does our one year outlook change? Century Plyboards (India) (CPBI) 2QFY17 revenues grew by 6% yoy driven by 2% yoy growth in plywood products and 11% yoy growth in laminate products.

More information

MCX Ltd. Rating: Target price: EPS: Tepid volume growth continues. Target. Rating CMP. Rs. 1,080 SELL. Rs. 1,176

MCX Ltd. Rating: Target price: EPS: Tepid volume growth continues. Target. Rating CMP. Rs. 1,080 SELL. Rs. 1,176 : price: EPS: Tepid volume growth continues 4QFY15 traded volumes in MCX showed a small improvement sequentially whereas declined yoy. FY15 traded Values are at a sever year low. We retain our cautious

More information

Quiet quarter, attractive valuation

Quiet quarter, attractive valuation Result Preview 15-Apr-13 Aker Sector: Industrial Conglomerates Recommendation: BUY (unchanged) Target price (NOK): 260 (unchanged) Analyst: Terje Mauer Tel: +47 22 01 63 24 E-mail: terje.mauer@platou.com

More information

24 May 2016 Energiekontor AG. FIRST BERLIN Equity Research

24 May 2016 Energiekontor AG. FIRST BERLIN Equity Research FIRST BERLIN Equity Research Energiekontor AG RATING Germany / Cleantech Frankfurt Stock Exchange Q1 update PRICE TARGET 18.00 Bloomberg: EKT GR Return Potential 30.3% ISIN: DE0005313506 Risk Rating High

More information

J&P Avax. 3Q10 preview. Greece, Construction. November 19, 2010

J&P Avax. 3Q10 preview. Greece, Construction. November 19, 2010 Greece, Construction J&P Avax 3Q10 preview November 19, 2010 Current price 1.28 Target price 4.20 From 4.20 Upside potential 228.1% Remains Outperform Key data Reuters code AVAr.AT Bloomberg code AVAX

More information

Sipchem Petrochemicals Industrial SIPCHEM AB: Saudi Arabia 07 August 2014

Sipchem Petrochemicals Industrial SIPCHEM AB: Saudi Arabia 07 August 2014 RSI10 Sipchem SIPCHEM AB: Saudi Arabia Rating Target price Current price NEUTRAL SAR40.98 (7.6% upside) SAR38.10 Sector rating Company risk rating Key themes & implications Outperform Low Sipchem recently

More information

ITC. Rating: Target price: EPS: Relative better visibility despite the smoke, Maintain BUY CMP. Target. Rating. Rs.389. Buy. Rs.

ITC. Rating: Target price: EPS: Relative better visibility despite the smoke, Maintain BUY CMP. Target. Rating. Rs.389. Buy. Rs. : price: EPS: Relative better visibility despite the smoke, Maintain BUY ITC reported revenues of Rs.~87.2bn (+13% y-o-y), operating profits of Rs.32.8bn (+15% y-o-y) and PAT of Rs.~23.8bn (+16% y-o-y).

More information

Fila Korea (081660) Widespread growth potential

Fila Korea (081660) Widespread growth potential Fila Korea (8166) BUY (Maintain), TP: W98, (Maintain) Stock price (Apr 26, KRW) 83,5 Yr to Sales OP EBT NP EPS % chg EBITDA P/E EV/EBITDA P/B ROE Market cap (USD mn) 697 Dec (W bn) (W bn) (W bn) (W bn)

More information